| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Homeodomain Proteins | 5 | 2018 | 93 | 1.38 | Why? |
| Republic of Korea | 31 | 2021 | 5858 | 1.09 | Why? |
| Obesity, Metabolically Benign | 1 | 2019 | 20 | 0.80 | Why? |
| Dementia, Vascular | 1 | 2019 | 33 | 0.78 | Why? |
| Mandible | 2 | 2019 | 72 | 0.78 | Why? |
| Cuspid | 1 | 2018 | 4 | 0.78 | Why? |
| Tooth, Impacted | 1 | 2018 | 12 | 0.76 | Why? |
| Thinness | 1 | 2019 | 99 | 0.75 | Why? |
| Muscle Contraction | 2 | 2018 | 60 | 0.74 | Why? |
| Abdominal Muscles | 1 | 2018 | 26 | 0.73 | Why? |
| Neoplasms, Connective Tissue | 1 | 2017 | 5 | 0.72 | Why? |
| Placenta Previa | 1 | 2017 | 21 | 0.71 | Why? |
| Emergency Medical Dispatcher | 1 | 2017 | 11 | 0.70 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 10 | 2019 | 8843 | 0.68 | Why? |
| Transcriptional Activation | 1 | 2018 | 196 | 0.68 | Why? |
| Rescue Work | 1 | 2017 | 47 | 0.66 | Why? |
| Postural Balance | 1 | 2018 | 144 | 0.65 | Why? |
| Microwaves | 1 | 2017 | 88 | 0.65 | Why? |
| Fibroblast Growth Factors | 1 | 2017 | 119 | 0.64 | Why? |
| Veins | 1 | 2017 | 168 | 0.63 | Why? |
| Postpartum Hemorrhage | 1 | 2017 | 144 | 0.62 | Why? |
| Global Burden of Disease | 1 | 2020 | 531 | 0.62 | Why? |
| Maxilla | 5 | 2019 | 70 | 0.62 | Why? |
| Neoplasm Invasiveness | 1 | 2018 | 582 | 0.61 | Why? |
| Laryngoscopes | 1 | 2017 | 121 | 0.61 | Why? |
| Sodium Chloride | 1 | 2017 | 203 | 0.60 | Why? |
| Iatrogenic Disease | 1 | 2017 | 304 | 0.56 | Why? |
| Surgery, Oral | 1 | 2019 | 240 | 0.55 | Why? |
| Cephalometry | 6 | 2018 | 41 | 0.55 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2017 | 319 | 0.50 | Why? |
| Laryngoscopy | 1 | 2017 | 413 | 0.48 | Why? |
| Lower Extremity | 1 | 2018 | 593 | 0.48 | Why? |
| Alzheimer Disease | 2 | 2019 | 1020 | 0.47 | Why? |
| Testis | 1 | 2017 | 566 | 0.46 | Why? |
| Video Recording | 1 | 2017 | 786 | 0.44 | Why? |
| Metabolic Syndrome | 1 | 2019 | 810 | 0.44 | Why? |
| Hypoxia | 2 | 2020 | 3626 | 0.43 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.43 | Why? |
| Embryonic Stem Cells | 2 | 2017 | 66 | 0.42 | Why? |
| Drug Overdose | 1 | 2017 | 583 | 0.41 | Why? |
| Placenta | 2 | 2018 | 1531 | 0.40 | Why? |
| Exercise | 3 | 2018 | 6771 | 0.38 | Why? |
| Osteopontin | 1 | 2010 | 96 | 0.38 | Why? |
| Exercise Therapy | 1 | 2018 | 976 | 0.37 | Why? |
| Receptors, Immunologic | 1 | 2012 | 555 | 0.37 | Why? |
| Tissue Banks | 1 | 2008 | 66 | 0.36 | Why? |
| Malocclusion, Angle Class III | 2 | 2018 | 9 | 0.36 | Why? |
| Breast Neoplasms | 4 | 2018 | 3633 | 0.35 | Why? |
| Oxides | 2 | 2018 | 77 | 0.35 | Why? |
| Hippocampus | 1 | 2010 | 237 | 0.34 | Why? |
| Disease Outbreaks | 10 | 2020 | 27595 | 0.33 | Why? |
| Membrane Proteins | 2 | 2017 | 1733 | 0.31 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.31 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.30 | Why? |
| Glucose | 1 | 2010 | 573 | 0.29 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.29 | Why? |
| Silver | 2 | 2018 | 327 | 0.28 | Why? |
| Blood Proteins | 1 | 2008 | 551 | 0.28 | Why? |
| Cryopreservation | 1 | 2008 | 464 | 0.28 | Why? |
| Occupational Diseases | 2 | 2017 | 2787 | 0.27 | Why? |
| Graphite | 2 | 2018 | 318 | 0.27 | Why? |
| Female | 60 | 2021 | 380317 | 0.27 | Why? |
| Coronavirus Infections | 25 | 2020 | 253789 | 0.27 | Why? |
| Alanine Transaminase | 2 | 2020 | 1329 | 0.27 | Why? |
| Diabetes Mellitus | 4 | 2020 | 8207 | 0.27 | Why? |
| C-Reactive Protein | 6 | 2020 | 7972 | 0.26 | Why? |
| Bacterial Proteins | 1 | 2012 | 1318 | 0.26 | Why? |
| Aspartate Aminotransferases | 2 | 2020 | 1394 | 0.26 | Why? |
| Male | 57 | 2021 | 367725 | 0.25 | Why? |
| Flow Cytometry | 3 | 2019 | 2393 | 0.25 | Why? |
| Gene Expression Regulation | 3 | 2017 | 4020 | 0.25 | Why? |
| Pneumonia | 4 | 2018 | 5652 | 0.23 | Why? |
| CCCTC-Binding Factor | 2 | 2018 | 6 | 0.23 | Why? |
| Malocclusion, Angle Class I | 2 | 2018 | 2 | 0.23 | Why? |
| Respiratory Insufficiency | 3 | 2020 | 7301 | 0.23 | Why? |
| Facial Asymmetry | 2 | 2017 | 9 | 0.23 | Why? |
| Intubation, Intratracheal | 1 | 2017 | 3962 | 0.23 | Why? |
| Health Personnel | 6 | 2021 | 29646 | 0.22 | Why? |
| NF-kappa B | 2 | 2019 | 1301 | 0.22 | Why? |
| Molar | 2 | 2017 | 23 | 0.22 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.20 | Why? |
| Rubus | 1 | 2019 | 7 | 0.20 | Why? |
| Humans | 72 | 2021 | 930598 | 0.20 | Why? |
| Alveolar Process | 1 | 2018 | 10 | 0.19 | Why? |
| Root Resorption | 1 | 2018 | 9 | 0.19 | Why? |
| Tooth Eruption | 1 | 2018 | 5 | 0.19 | Why? |
| Lymphocytosis | 1 | 2020 | 122 | 0.19 | Why? |
| Pyrazinamide | 1 | 2019 | 38 | 0.19 | Why? |
| Fractionation, Field Flow | 1 | 2018 | 13 | 0.19 | Why? |
| Antigens, CD34 | 1 | 2019 | 125 | 0.19 | Why? |
| Single Parent | 1 | 2018 | 4 | 0.19 | Why? |
| Peptidoglycan | 1 | 2018 | 27 | 0.19 | Why? |
| Tooth Movement Techniques | 1 | 2018 | 19 | 0.19 | Why? |
| Periodontics | 1 | 2018 | 9 | 0.19 | Why? |
| Asteraceae | 1 | 2018 | 15 | 0.19 | Why? |
| Hyoid Bone | 1 | 2018 | 4 | 0.19 | Why? |
| Aged | 32 | 2020 | 215776 | 0.19 | Why? |
| Fibroblasts | 3 | 2017 | 839 | 0.19 | Why? |
| Rad51 Recombinase | 1 | 2017 | 6 | 0.19 | Why? |
| Nitroimidazoles | 1 | 2019 | 69 | 0.19 | Why? |
| Tooth Loss | 1 | 2018 | 13 | 0.19 | Why? |
| Prosthodontics | 1 | 2018 | 21 | 0.19 | Why? |
| Oxazoles | 1 | 2019 | 75 | 0.18 | Why? |
| Traction | 1 | 2018 | 19 | 0.18 | Why? |
| Myocardium | 3 | 2020 | 2323 | 0.18 | Why? |
| Methyl Ethers | 1 | 2018 | 22 | 0.18 | Why? |
| Heart Rate | 2 | 2018 | 1527 | 0.18 | Why? |
| Osteomalacia | 1 | 2017 | 5 | 0.18 | Why? |
| Candida glabrata | 1 | 2018 | 50 | 0.18 | Why? |
| Middle Aged | 38 | 2021 | 270681 | 0.18 | Why? |
| Lettuce | 1 | 2017 | 15 | 0.18 | Why? |
| 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2017 | 4 | 0.18 | Why? |
| Muscle, Smooth | 1 | 2018 | 67 | 0.18 | Why? |
| Motor Neurons | 1 | 2018 | 52 | 0.18 | Why? |
| Corneal Dystrophies, Hereditary | 1 | 2017 | 2 | 0.18 | Why? |
| Levofloxacin | 1 | 2019 | 115 | 0.18 | Why? |
| Tooth Eruption, Ectopic | 1 | 2017 | 1 | 0.18 | Why? |
| Adult | 33 | 2021 | 244371 | 0.18 | Why? |
| Quadriceps Muscle | 1 | 2018 | 50 | 0.18 | Why? |
| Chlorophyta | 1 | 2017 | 36 | 0.18 | Why? |
| M Phase Cell Cycle Checkpoints | 1 | 2017 | 9 | 0.17 | Why? |
| Histone Acetyltransferases | 1 | 2017 | 27 | 0.17 | Why? |
| Dietary Proteins | 1 | 2018 | 112 | 0.17 | Why? |
| Tamoxifen | 1 | 2018 | 83 | 0.17 | Why? |
| Enterococcus faecalis | 1 | 2018 | 126 | 0.17 | Why? |
| Uterus | 1 | 2018 | 98 | 0.17 | Why? |
| Paraneoplastic Syndromes | 1 | 2017 | 28 | 0.17 | Why? |
| Cardiotoxins | 1 | 2017 | 22 | 0.17 | Why? |
| Hepatocyte Growth Factor | 1 | 2017 | 71 | 0.17 | Why? |
| Linezolid | 1 | 2019 | 160 | 0.17 | Why? |
| Octreotide | 1 | 2017 | 56 | 0.17 | Why? |
| Tretinoin | 1 | 2018 | 99 | 0.17 | Why? |
| Radionuclide Imaging | 1 | 2019 | 184 | 0.17 | Why? |
| Heart | 2 | 2018 | 1791 | 0.17 | Why? |
| Soil Microbiology | 1 | 2017 | 63 | 0.17 | Why? |
| Antifungal Agents | 2 | 2018 | 1828 | 0.17 | Why? |
| Young Adult | 18 | 2020 | 93724 | 0.17 | Why? |
| Orientation | 1 | 2017 | 15 | 0.17 | Why? |
| Nanocomposites | 1 | 2017 | 62 | 0.17 | Why? |
| Stomach | 1 | 2018 | 141 | 0.17 | Why? |
| Fluconazole | 1 | 2018 | 145 | 0.17 | Why? |
| Nuclear Matrix-Associated Proteins | 1 | 2017 | 50 | 0.17 | Why? |
| Retrospective Studies | 17 | 2020 | 105322 | 0.17 | Why? |
| Progesterone | 1 | 2018 | 106 | 0.17 | Why? |
| Magnetic Resonance Imaging | 4 | 2018 | 6551 | 0.17 | Why? |
| Cellulose | 1 | 2017 | 106 | 0.17 | Why? |
| Stress Disorders, Post-Traumatic | 3 | 2018 | 2963 | 0.17 | Why? |
| Postoperative Complications | 2 | 2017 | 5861 | 0.17 | Why? |
| Nucleocytoplasmic Transport Proteins | 1 | 2017 | 73 | 0.17 | Why? |
| Plant Extracts | 2 | 2019 | 1514 | 0.16 | Why? |
| Autonomic Nervous System | 1 | 2018 | 148 | 0.16 | Why? |
| Arthroscopy | 1 | 2017 | 46 | 0.16 | Why? |
| Solvents | 1 | 2018 | 139 | 0.16 | Why? |
| Tongue | 1 | 2018 | 132 | 0.16 | Why? |
| Drug Resistance, Fungal | 1 | 2018 | 191 | 0.16 | Why? |
| Shoulder | 1 | 2017 | 96 | 0.16 | Why? |
| Lipoproteins | 1 | 2018 | 240 | 0.16 | Why? |
| Mice | 9 | 2019 | 21357 | 0.16 | Why? |
| Hyperlipidemias | 1 | 2019 | 290 | 0.16 | Why? |
| Ophthalmic Solutions | 1 | 2017 | 136 | 0.16 | Why? |
| Single-Blind Method | 2 | 2017 | 1283 | 0.16 | Why? |
| Respiration, Artificial | 3 | 2020 | 22116 | 0.16 | Why? |
| Antibiotics, Antineoplastic | 1 | 2017 | 128 | 0.16 | Why? |
| Plant Leaves | 1 | 2017 | 233 | 0.16 | Why? |
| Triglycerides | 1 | 2019 | 478 | 0.16 | Why? |
| Hospital Rapid Response Team | 1 | 2017 | 100 | 0.16 | Why? |
| Antineoplastic Agents, Hormonal | 1 | 2018 | 203 | 0.16 | Why? |
| ErbB Receptors | 1 | 2018 | 320 | 0.16 | Why? |
| Psychomotor Performance | 1 | 2017 | 110 | 0.16 | Why? |
| Age Factors | 6 | 2020 | 21039 | 0.16 | Why? |
| Pneumonia, Viral | 13 | 2020 | 243684 | 0.15 | Why? |
| Water Microbiology | 1 | 2018 | 248 | 0.15 | Why? |
| Electromyography | 1 | 2018 | 278 | 0.15 | Why? |
| Multivariate Analysis | 4 | 2020 | 5440 | 0.15 | Why? |
| Cardiopulmonary Bypass | 1 | 2017 | 158 | 0.15 | Why? |
| Methanol | 1 | 2018 | 149 | 0.15 | Why? |
| Cholesterol, HDL | 1 | 2019 | 439 | 0.15 | Why? |
| Cross Infection | 5 | 2020 | 8675 | 0.15 | Why? |
| Tissue Scaffolds | 1 | 2017 | 174 | 0.15 | Why? |
| Hospitals, Special | 1 | 2020 | 523 | 0.15 | Why? |
| Tissue Engineering | 1 | 2017 | 190 | 0.15 | Why? |
| Fluorescence | 1 | 2018 | 475 | 0.15 | Why? |
| Periodontitis | 1 | 2018 | 171 | 0.15 | Why? |
| Hypercapnia | 1 | 2017 | 172 | 0.15 | Why? |
| Chromatin | 1 | 2016 | 107 | 0.15 | Why? |
| Dexmedetomidine | 1 | 2017 | 130 | 0.15 | Why? |
| Propofol | 1 | 2018 | 172 | 0.15 | Why? |
| Nanoparticles | 2 | 2017 | 2040 | 0.15 | Why? |
| Birth Weight | 1 | 2017 | 250 | 0.15 | Why? |
| Cholesterol, LDL | 1 | 2019 | 499 | 0.15 | Why? |
| Organ Culture Techniques | 2 | 2018 | 119 | 0.15 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 436 | 0.14 | Why? |
| Organometallic Compounds | 1 | 2017 | 206 | 0.14 | Why? |
| Chitosan | 1 | 2017 | 196 | 0.14 | Why? |
| Aged, 80 and over | 13 | 2020 | 88759 | 0.14 | Why? |
| Doxorubicin | 1 | 2017 | 313 | 0.14 | Why? |
| Foramen Ovale, Patent | 1 | 2017 | 153 | 0.14 | Why? |
| Hospital Mortality | 5 | 2020 | 22087 | 0.14 | Why? |
| Resistance Training | 1 | 2018 | 273 | 0.14 | Why? |
| Phosphorylation | 1 | 2018 | 1060 | 0.14 | Why? |
| Drug Resistance, Neoplasm | 1 | 2018 | 447 | 0.14 | Why? |
| Risk Factors | 12 | 2020 | 71621 | 0.14 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.14 | Why? |
| Cells, Cultured | 4 | 2018 | 5835 | 0.14 | Why? |
| Oligopeptides | 1 | 2018 | 576 | 0.14 | Why? |
| Stress, Psychological | 2 | 2021 | 10231 | 0.14 | Why? |
| Animals | 16 | 2020 | 78931 | 0.14 | Why? |
| Protective Agents | 1 | 2017 | 250 | 0.14 | Why? |
| Histones | 1 | 2017 | 371 | 0.14 | Why? |
| Neutropenia | 1 | 2018 | 388 | 0.14 | Why? |
| Repressor Proteins | 1 | 2016 | 232 | 0.14 | Why? |
| Lactic Acid | 1 | 2017 | 393 | 0.14 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2017 | 242 | 0.14 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2018 | 669 | 0.14 | Why? |
| Autoantigens | 1 | 2017 | 388 | 0.14 | Why? |
| Platelet Count | 1 | 2020 | 1381 | 0.14 | Why? |
| Earthquakes | 1 | 2017 | 165 | 0.14 | Why? |
| Pleural Effusion | 1 | 2020 | 680 | 0.14 | Why? |
| Personality | 1 | 2018 | 277 | 0.13 | Why? |
| Candidemia | 1 | 2018 | 353 | 0.13 | Why? |
| Lung Neoplasms | 1 | 2011 | 3228 | 0.13 | Why? |
| NF-E2-Related Factor 2 | 1 | 2018 | 373 | 0.13 | Why? |
| Candida | 1 | 2018 | 425 | 0.13 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.13 | Why? |
| Nutritional Support | 1 | 2018 | 447 | 0.13 | Why? |
| Glomerular Filtration Rate | 2 | 2017 | 1262 | 0.13 | Why? |
| Candidiasis | 1 | 2018 | 334 | 0.13 | Why? |
| Cardiotoxicity | 1 | 2017 | 365 | 0.13 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 552 | 0.13 | Why? |
| Acute Kidney Injury | 3 | 2020 | 5762 | 0.13 | Why? |
| Trisaccharides | 1 | 2012 | 8 | 0.13 | Why? |
| Fetus | 1 | 2017 | 484 | 0.13 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2019 | 433 | 0.13 | Why? |
| Occupational Therapy | 1 | 2017 | 228 | 0.13 | Why? |
| Pregnancy | 5 | 2020 | 23879 | 0.13 | Why? |
| Ischemic Attack, Transient | 1 | 2017 | 439 | 0.13 | Why? |
| Stroke Rehabilitation | 1 | 2017 | 299 | 0.13 | Why? |
| Cell Survival | 3 | 2019 | 1581 | 0.12 | Why? |
| Hyaline Cartilage | 1 | 2011 | 2 | 0.12 | Why? |
| CD4 Lymphocyte Count | 1 | 2018 | 1517 | 0.12 | Why? |
| Nepal | 1 | 2017 | 1004 | 0.12 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.12 | Why? |
| Middle East | 1 | 2017 | 1418 | 0.12 | Why? |
| Tandem Mass Spectrometry | 1 | 2018 | 1031 | 0.12 | Why? |
| Antitubercular Agents | 1 | 2019 | 775 | 0.12 | Why? |
| Anesthesia, General | 1 | 2017 | 470 | 0.12 | Why? |
| Bone Marrow Diseases | 1 | 2011 | 27 | 0.12 | Why? |
| Epigenesis, Genetic | 1 | 2018 | 711 | 0.12 | Why? |
| Vertebrates | 1 | 2012 | 127 | 0.12 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.11 | Why? |
| Rats, Sprague-Dawley | 2 | 2018 | 987 | 0.11 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.11 | Why? |
| Cartilage, Articular | 1 | 2011 | 50 | 0.11 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.11 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.11 | Why? |
| Mass Screening | 3 | 2020 | 8005 | 0.11 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.11 | Why? |
| Logistic Models | 2 | 2020 | 9089 | 0.11 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.11 | Why? |
| Proportional Hazards Models | 2 | 2020 | 6543 | 0.11 | Why? |
| Anemia | 1 | 2018 | 789 | 0.11 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 1115 | 0.10 | Why? |
| Air Microbiology | 1 | 2020 | 1322 | 0.10 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.10 | Why? |
| Hydrogen Bonding | 1 | 2012 | 599 | 0.10 | Why? |
| Microfilament Proteins | 1 | 2010 | 45 | 0.10 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.10 | Why? |
| Melatonin | 1 | 2017 | 578 | 0.10 | Why? |
| Ribavirin | 1 | 2017 | 1182 | 0.10 | Why? |
| Pharynx | 1 | 2018 | 1544 | 0.10 | Why? |
| Phosphopyruvate Hydratase | 1 | 2010 | 47 | 0.10 | Why? |
| Interdisciplinary Communication | 1 | 2018 | 1425 | 0.10 | Why? |
| Carbon Monoxide | 1 | 2011 | 167 | 0.10 | Why? |
| Glial Fibrillary Acidic Protein | 1 | 2010 | 138 | 0.10 | Why? |
| Prognosis | 5 | 2020 | 32490 | 0.10 | Why? |
| Stage-Specific Embryonic Antigens | 1 | 2008 | 1 | 0.10 | Why? |
| Ambulatory Care Facilities | 2 | 2020 | 2063 | 0.10 | Why? |
| CCAAT-Enhancer-Binding Proteins | 1 | 2008 | 17 | 0.10 | Why? |
| Environmental Exposure | 1 | 2020 | 1558 | 0.10 | Why? |
| Vital Capacity | 1 | 2011 | 399 | 0.10 | Why? |
| Lipopolysaccharides | 3 | 2019 | 848 | 0.10 | Why? |
| Protein Binding | 4 | 2018 | 11430 | 0.10 | Why? |
| Karyotyping | 1 | 2008 | 52 | 0.10 | Why? |
| Mycobacterium tuberculosis | 1 | 2019 | 1164 | 0.10 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.10 | Why? |
| Acute Lung Injury | 1 | 2018 | 904 | 0.10 | Why? |
| Calcium-Binding Proteins | 1 | 2010 | 121 | 0.10 | Why? |
| Anti-Inflammatory Agents | 2 | 2019 | 6153 | 0.10 | Why? |
| Sex Characteristics | 1 | 2017 | 1120 | 0.10 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2020 | 13720 | 0.09 | Why? |
| Animals, Newborn | 1 | 2010 | 350 | 0.09 | Why? |
| Osteoarthritis, Knee | 1 | 2011 | 158 | 0.09 | Why? |
| Immunomodulation | 1 | 2018 | 1472 | 0.09 | Why? |
| Qualitative Research | 2 | 2021 | 4337 | 0.09 | Why? |
| Treatment Outcome | 6 | 2020 | 51732 | 0.09 | Why? |
| Suicidal Ideation | 1 | 2018 | 1226 | 0.09 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.09 | Why? |
| Radiography, Panoramic | 2 | 2018 | 26 | 0.09 | Why? |
| Forced Expiratory Volume | 1 | 2011 | 632 | 0.09 | Why? |
| Radiography, Dental | 2 | 2018 | 38 | 0.09 | Why? |
| Tuberculosis, Pulmonary | 1 | 2019 | 1171 | 0.09 | Why? |
| Bone Marrow | 1 | 2011 | 492 | 0.09 | Why? |
| MCF-7 Cells | 2 | 2018 | 199 | 0.09 | Why? |
| Protein Structure, Tertiary | 1 | 2012 | 1565 | 0.09 | Why? |
| RAW 264.7 Cells | 2 | 2019 | 316 | 0.09 | Why? |
| Sleep | 2 | 2018 | 2695 | 0.09 | Why? |
| Host-Pathogen Interactions | 2 | 2019 | 11041 | 0.09 | Why? |
| Alkaline Phosphatase | 1 | 2008 | 257 | 0.09 | Why? |
| Ventilators, Mechanical | 1 | 2020 | 2193 | 0.09 | Why? |
| Killer Cells, Natural | 1 | 2018 | 2093 | 0.09 | Why? |
| Hospitals | 4 | 2020 | 11793 | 0.09 | Why? |
| Interviews as Topic | 1 | 2017 | 1952 | 0.08 | Why? |
| Erythrocyte Transfusion | 1 | 2011 | 386 | 0.08 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.08 | Why? |
| Green Fluorescent Proteins | 1 | 2008 | 450 | 0.08 | Why? |
| Mothers | 1 | 2018 | 1624 | 0.08 | Why? |
| Tissue and Organ Harvesting | 1 | 2008 | 146 | 0.08 | Why? |
| Rats | 2 | 2018 | 2764 | 0.08 | Why? |
| Incidence | 4 | 2019 | 25622 | 0.08 | Why? |
| Occupational Stress | 1 | 2021 | 2044 | 0.08 | Why? |
| Thrombocytopenia | 1 | 2020 | 2093 | 0.08 | Why? |
| Veterans | 1 | 2017 | 1131 | 0.08 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.08 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.08 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.08 | Why? |
| Saudi Arabia | 1 | 2017 | 4423 | 0.08 | Why? |
| Protein Conformation | 2 | 2018 | 4386 | 0.08 | Why? |
| Posture | 2 | 2018 | 199 | 0.08 | Why? |
| Cough | 1 | 2020 | 4891 | 0.08 | Why? |
| Adolescent | 8 | 2020 | 86841 | 0.08 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 1322 | 0.08 | Why? |
| Diabetes Complications | 1 | 2018 | 2358 | 0.07 | Why? |
| Child | 6 | 2020 | 70012 | 0.07 | Why? |
| Epidemiological Monitoring | 1 | 2018 | 3493 | 0.07 | Why? |
| Dementia | 1 | 2019 | 1861 | 0.07 | Why? |
| Immunoglobulin A | 1 | 2017 | 3567 | 0.07 | Why? |
| Crystallography, X-Ray | 1 | 2012 | 2689 | 0.07 | Why? |
| Signal Transduction | 2 | 2019 | 7207 | 0.07 | Why? |
| Kidney | 2 | 2017 | 3648 | 0.07 | Why? |
| Escherichia coli | 1 | 2012 | 1547 | 0.07 | Why? |
| Odds Ratio | 2 | 2020 | 5861 | 0.07 | Why? |
| Blood Glucose | 1 | 2019 | 3642 | 0.07 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.07 | Why? |
| Proteins | 1 | 2012 | 921 | 0.07 | Why? |
| Wounds and Injuries | 1 | 2018 | 1708 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.07 | Why? |
| Renal Insufficiency, Chronic | 1 | 2019 | 2654 | 0.07 | Why? |
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 372 | 0.07 | Why? |
| Point-of-Care Systems | 1 | 2018 | 2955 | 0.07 | Why? |
| Neoplasm Staging | 1 | 2011 | 1999 | 0.07 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.07 | Why? |
| Time Factors | 6 | 2020 | 31397 | 0.07 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.07 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.07 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.07 | Why? |
| Stroke | 2 | 2017 | 8839 | 0.06 | Why? |
| Rabbits | 2 | 2017 | 1171 | 0.06 | Why? |
| Child, Preschool | 4 | 2020 | 36283 | 0.06 | Why? |
| Neurons | 1 | 2010 | 864 | 0.06 | Why? |
| Cohort Studies | 4 | 2020 | 36005 | 0.06 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4545 | 0.06 | Why? |
| Cell Differentiation | 1 | 2008 | 1338 | 0.06 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Recombinant Proteins | 1 | 2012 | 3786 | 0.06 | Why? |
| Pandemics | 13 | 2020 | 389249 | 0.06 | Why? |
| Evolution, Molecular | 1 | 2016 | 3691 | 0.06 | Why? |
| Asthma | 1 | 2020 | 4383 | 0.06 | Why? |
| Lung | 3 | 2020 | 31049 | 0.06 | Why? |
| Tertiary Care Centers | 4 | 2020 | 8248 | 0.06 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.06 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.06 | Why? |
| Severity of Illness Index | 5 | 2020 | 48226 | 0.06 | Why? |
| Infant | 3 | 2020 | 30274 | 0.05 | Why? |
| Renal Dialysis | 1 | 2018 | 4358 | 0.05 | Why? |
| Seroepidemiologic Studies | 1 | 2016 | 10017 | 0.05 | Why? |
| Air | 1 | 2020 | 145 | 0.05 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.05 | Why? |
| Lymphocytes | 1 | 2012 | 3056 | 0.05 | Why? |
| Disease Models, Animal | 4 | 2018 | 10998 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2017 | 22971 | 0.05 | Why? |
| Immunoglobulin M | 1 | 2017 | 9091 | 0.05 | Why? |
| Tooth Apex | 1 | 2018 | 3 | 0.05 | Why? |
| Leukocyte Common Antigens | 1 | 2019 | 101 | 0.05 | Why? |
| Incisor | 1 | 2018 | 11 | 0.05 | Why? |
| Creatinine | 2 | 2016 | 1443 | 0.05 | Why? |
| Kaplan-Meier Estimate | 2 | 2020 | 4260 | 0.05 | Why? |
| Tetrodotoxin | 1 | 2018 | 8 | 0.05 | Why? |
| Muscle Relaxation | 1 | 2018 | 12 | 0.05 | Why? |
| Atropine | 1 | 2018 | 18 | 0.05 | Why? |
| Extraoral Traction Appliances | 1 | 2018 | 2 | 0.05 | Why? |
| Prospective Studies | 3 | 2020 | 43301 | 0.05 | Why? |
| Free Radical Scavengers | 1 | 2019 | 82 | 0.05 | Why? |
| Metabolic Equivalent | 1 | 2018 | 17 | 0.05 | Why? |
| Esthetics, Dental | 1 | 2018 | 24 | 0.05 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.05 | Why? |
| Xylosidases | 1 | 2017 | 1 | 0.05 | Why? |
| Cellulose 1,4-beta-Cellobiosidase | 1 | 2017 | 2 | 0.05 | Why? |
| Nitrification | 1 | 2017 | 4 | 0.05 | Why? |
| Ikaros Transcription Factor | 1 | 2017 | 10 | 0.05 | Why? |
| Drug Screening Assays, Antitumor | 1 | 2018 | 138 | 0.05 | Why? |
| Sumoylation | 1 | 2017 | 21 | 0.05 | Why? |
| beta-Glucosidase | 1 | 2017 | 7 | 0.05 | Why? |
| Anesthetics, General | 1 | 2018 | 12 | 0.05 | Why? |
| Cell Line, Tumor | 2 | 2018 | 3608 | 0.05 | Why? |
| Temperature | 1 | 2008 | 2305 | 0.05 | Why? |
| Creatine Kinase, MB Form | 1 | 2020 | 259 | 0.05 | Why? |
| Night Care | 1 | 2017 | 10 | 0.05 | Why? |
| Equivalence Trials as Topic | 1 | 2019 | 242 | 0.05 | Why? |
| Electric Stimulation | 1 | 2018 | 84 | 0.05 | Why? |
| Anatomic Landmarks | 1 | 2017 | 44 | 0.05 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.05 | Why? |
| Obesity | 1 | 2019 | 7388 | 0.04 | Why? |
| Hematocrit | 1 | 2018 | 107 | 0.04 | Why? |
| Dental Arch | 1 | 2017 | 2 | 0.04 | Why? |
| Seoul | 1 | 2018 | 206 | 0.04 | Why? |
| Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 40 | 0.04 | Why? |
| Biomass | 1 | 2017 | 80 | 0.04 | Why? |
| Telomere Homeostasis | 1 | 2017 | 52 | 0.04 | Why? |
| Combat Disorders | 1 | 2017 | 15 | 0.04 | Why? |
| Echinocandins | 1 | 2018 | 139 | 0.04 | Why? |
| Acetylation | 1 | 2017 | 124 | 0.04 | Why? |
| Bicuspid | 1 | 2017 | 9 | 0.04 | Why? |
| Hypoventilation | 1 | 2017 | 17 | 0.04 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.04 | Why? |
| Receptors, Estrogen | 1 | 2018 | 171 | 0.04 | Why? |
| Hypertension | 1 | 2019 | 8895 | 0.04 | Why? |
| Coculture Techniques | 1 | 2018 | 258 | 0.04 | Why? |
| beta-Cyclodextrins | 1 | 2017 | 87 | 0.04 | Why? |
| Neutrophil Infiltration | 1 | 2018 | 201 | 0.04 | Why? |
| Reverse Transcription | 1 | 2020 | 673 | 0.04 | Why? |
| Nitrogen | 1 | 2017 | 106 | 0.04 | Why? |
| Amphotericin B | 1 | 2018 | 256 | 0.04 | Why? |
| Neural Pathways | 1 | 2018 | 155 | 0.04 | Why? |
| Soil | 1 | 2017 | 137 | 0.04 | Why? |
| Tachypnea | 1 | 2017 | 197 | 0.04 | Why? |
| Fruit | 1 | 2019 | 313 | 0.04 | Why? |
| Bed Occupancy | 1 | 2020 | 476 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Transplantation, Autologous | 1 | 2017 | 364 | 0.04 | Why? |
| Ubiquitination | 1 | 2018 | 343 | 0.04 | Why? |
| Cone-Beam Computed Tomography | 1 | 2017 | 118 | 0.04 | Why? |
| Image Enhancement | 1 | 2018 | 177 | 0.04 | Why? |
| Hematopoietic Stem Cells | 1 | 2019 | 321 | 0.04 | Why? |
| Solubility | 1 | 2017 | 382 | 0.04 | Why? |
| DNA, Mitochondrial | 1 | 2017 | 163 | 0.04 | Why? |
| Substrate Specificity | 1 | 2018 | 639 | 0.04 | Why? |
| Accelerometry | 1 | 2018 | 228 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Inservice Training | 1 | 2020 | 477 | 0.04 | Why? |
| Telomere | 1 | 2017 | 146 | 0.04 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.04 | Why? |
| Radiography | 2 | 2016 | 1576 | 0.04 | Why? |
| Gene Knockdown Techniques | 1 | 2017 | 347 | 0.04 | Why? |
| Intraoperative Care | 1 | 2017 | 238 | 0.04 | Why? |
| Gene Expression Regulation, Developmental | 1 | 2016 | 159 | 0.04 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.04 | Why? |
| DNA Damage | 1 | 2017 | 285 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2020 | 1654 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2019 | 801 | 0.04 | Why? |
| Quarantine | 2 | 2020 | 18418 | 0.04 | Why? |
| Teaching Rounds | 1 | 2018 | 208 | 0.04 | Why? |
| Emergency Service, Hospital | 2 | 2020 | 14232 | 0.04 | Why? |
| Pulmonary Ventilation | 1 | 2017 | 152 | 0.04 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2016 | 207 | 0.04 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.04 | Why? |
| Neuroprotective Agents | 1 | 2018 | 240 | 0.04 | Why? |
| Arterial Pressure | 1 | 2017 | 208 | 0.04 | Why? |
| Multigene Family | 1 | 2016 | 377 | 0.04 | Why? |
| Mental Disorders | 1 | 2018 | 6742 | 0.04 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2019 | 782 | 0.03 | Why? |
| Patient Outcome Assessment | 1 | 2019 | 707 | 0.03 | Why? |
| Microscopy, Confocal | 1 | 2016 | 343 | 0.03 | Why? |
| Geography | 1 | 2020 | 1801 | 0.03 | Why? |
| Hematuria | 1 | 2015 | 284 | 0.03 | Why? |
| Models, Psychological | 1 | 2018 | 383 | 0.03 | Why? |
| Chemokine CXCL10 | 1 | 2018 | 565 | 0.03 | Why? |
| Heart Injuries | 1 | 2020 | 608 | 0.03 | Why? |
| Microscopy, Electron | 1 | 2016 | 830 | 0.03 | Why? |
| Ligands | 1 | 2018 | 1300 | 0.03 | Why? |
| Disease Progression | 3 | 2020 | 13580 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.03 | Why? |
| Blood Gas Analysis | 1 | 2017 | 893 | 0.03 | Why? |
| Chronic Disease | 2 | 2018 | 5139 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.03 | Why? |
| Molecular Structure | 1 | 2018 | 1539 | 0.03 | Why? |
| Mastectomy | 1 | 2018 | 536 | 0.03 | Why? |
| Disease Transmission, Infectious | 1 | 2016 | 9044 | 0.03 | Why? |
| Cornea | 1 | 2017 | 410 | 0.03 | Why? |
| Interleukin-1beta | 1 | 2018 | 992 | 0.03 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.03 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.03 | Why? |
| Water Pollutants, Chemical | 1 | 2018 | 410 | 0.03 | Why? |
| Surge Capacity | 1 | 2020 | 894 | 0.03 | Why? |
| Protective Clothing | 1 | 2016 | 468 | 0.03 | Why? |
| Quality Assurance, Health Care | 1 | 2017 | 596 | 0.03 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 669 | 0.03 | Why? |
| Stem Cell Transplantation | 1 | 2017 | 531 | 0.03 | Why? |
| Mutation | 1 | 2012 | 12376 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Cytokines | 3 | 2019 | 15010 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2020 | 1995 | 0.03 | Why? |
| Serum Albumin | 1 | 2016 | 571 | 0.03 | Why? |
| Proteinuria | 1 | 2015 | 474 | 0.03 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.03 | Why? |
| Intellectual Disability | 1 | 2018 | 391 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.03 | Why? |
| Mouth | 1 | 2017 | 622 | 0.03 | Why? |
| Regression Analysis | 1 | 2019 | 2484 | 0.03 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.03 | Why? |
| Catalytic Domain | 1 | 2018 | 1757 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2019 | 2437 | 0.03 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.03 | Why? |
| Tibia | 1 | 2011 | 72 | 0.03 | Why? |
| Intensive Care Units, Pediatric | 1 | 2018 | 1098 | 0.03 | Why? |
| Plants, Medicinal | 1 | 2018 | 622 | 0.03 | Why? |
| Psychiatric Status Rating Scales | 1 | 2018 | 1340 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2019 | 1387 | 0.03 | Why? |
| Femur | 1 | 2011 | 100 | 0.03 | Why? |
| DNA Methylation | 1 | 2016 | 688 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Phytotherapy | 1 | 2018 | 743 | 0.03 | Why? |
| Zinc | 1 | 2018 | 817 | 0.03 | Why? |
| Data Collection | 1 | 2020 | 1769 | 0.03 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.03 | Why? |
| Peptide Hydrolases | 1 | 2018 | 1269 | 0.03 | Why? |
| Mental Health | 1 | 2017 | 15770 | 0.03 | Why? |
| DNA | 1 | 2016 | 778 | 0.03 | Why? |
| Occupational Exposure | 2 | 2021 | 4742 | 0.03 | Why? |
| Crowding | 1 | 2016 | 731 | 0.03 | Why? |
| Linear Models | 1 | 2016 | 1914 | 0.03 | Why? |
| Interpersonal Relations | 1 | 2018 | 926 | 0.03 | Why? |
| Peptide Fragments | 1 | 2020 | 2075 | 0.02 | Why? |
| Knee Joint | 1 | 2011 | 194 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2016 | 1061 | 0.02 | Why? |
| Reagent Kits, Diagnostic | 1 | 2019 | 2149 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| History, 21st Century | 1 | 2016 | 1849 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Heart Ventricles | 1 | 2017 | 1139 | 0.02 | Why? |
| Pain Measurement | 1 | 2011 | 533 | 0.02 | Why? |
| Antibodies, Viral | 2 | 2019 | 51949 | 0.02 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.02 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Seroconversion | 1 | 2017 | 2515 | 0.02 | Why? |
| Macrophages | 1 | 2019 | 2784 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Biopsy | 1 | 2016 | 2811 | 0.02 | Why? |
| Heart Arrest | 1 | 2017 | 1239 | 0.02 | Why? |
| Social Support | 1 | 2021 | 3183 | 0.02 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
| Decision Making | 1 | 2021 | 3132 | 0.02 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2018 | 6049 | 0.02 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2017 | 1810 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2019 | 2782 | 0.02 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2019 | 7268 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2017 | 4002 | 0.02 | Why? |
| Health Status | 1 | 2018 | 3259 | 0.02 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.02 | Why? |
| Patient Care Team | 1 | 2018 | 3556 | 0.02 | Why? |
| Models, Molecular | 1 | 2018 | 7616 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Aging | 1 | 2020 | 3581 | 0.02 | Why? |
| Hospitals, University | 1 | 2016 | 4173 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Liver | 1 | 2017 | 4007 | 0.02 | Why? |
| Electronic Health Records | 1 | 2016 | 3492 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.02 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Developing Countries | 1 | 2018 | 4283 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Genetic Variation | 1 | 2016 | 3919 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.01 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Contact Tracing | 1 | 2016 | 8448 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2011 | 9893 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Genome, Viral | 1 | 2016 | 13157 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Depression | 1 | 2017 | 14116 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2019 | 25288 | 0.01 | Why? |
| Anxiety | 1 | 2017 | 17311 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2011 | 53120 | 0.00 | Why? |